Drug Company

Oct 29, 2014 at 16:51 | Source: CNBC-TV18
Discussing the companys results, GV Prasad co-chairman and CEO, DRL, said the quarter has been a flattish one on the back of high R&D expenses. He expects growth to return once launches start happening.
Oct 29, 2014 at 12:18 | Source:
Mangalam Drugs & Organics Ltd has informed BSE that Mrs. Meenal Sukhani has been appointed as Additional Director on the Board of the Company with effect from October 21, 2014. She will be Non - executive director of the Company.
Oct 28, 2014 at 14:24 | Source:
Trimurthi Drugs & Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on November 08, 2014, to transact the following items of business thereat: 1. To review the performance of the Company.
Oct 28, 2014 at 10:55 | Source:
Parabolic Drugs has submitted a copy of minutes of the proceedings of the 18th Annual General Meeting (AGM) of the Company held on September 30, 2014.
Oct 21, 2014 at 16:12 | Source: PTI
Terming the US as a high growth market for the company, the Mumbai-based firm said it aims to grow at around 25 percent in the world's largest drug market.
Oct 13, 2014 at 21:12 | Source:
Welcure Drugs & Pharmaceuticals has informed that Shri. D C Jain has resigned from the post of Company Secretaryship with effect from October 06, 2014 and Ms. Rashi Aggarwal, a qualified member of the Institute of Company Secretaries of India has been appointed as Company Secretary of the Company.
Oct 13, 2014 at 21:11 | Source:
Welcure Drugs & Pharmaceuticals has informed that Ms. Rashi Aggarwal has been appointed as Woman Independent director of the Company with effect from October 06, 2014.
Oct 13, 2014 at 21:11 | Source:
Welcure Drugs & Pharmaceuticals has informed that Shri R. K. Pandey has resigned from the post of directorship of the Company with effect from September 30, 2014.
Oct 09, 2014 at 16:36 | Source: CNBC-TV18
The PIL has argued that lifting the price cap with lead to windfall gains for pharma companies and that removing the price cap is unconstitutional against public interest.
Oct 09, 2014 at 13:12 | Source:
A JM financial probe said that the probability of any major action against generic pharma companies accused of inflating generic drug prices is low because such as precedent has not taken place in the past, there is uncertainty on the extent of price increases and cartellization may be difficult to prove.
Messages on Drug Company »


Gold Member


Dr Reddys Labs  

The US market continues to drive growth for Dr Reddy`s and other Indian generic drug companies. What if this paradigm changes in the global context? The US drives the growth but we have to diversify our sources of growth even though the relative importance of the US may not change. Emerging markets

8.53 PM Jun 30th

anil patil

Platinum Member


Aurobindo Pharm  

deal details with the stock exchanges showed. Morgan Stanley Asia Singapore, which is a shareholder of Aurobindo Pharma, sold 17,32,500 shares of the drug company for about Rs 670 apiece, valuing the transaction at Rs 116 crore. Morgan Stanley Asia Singapore held 46.16 lakh shares of Aurobindo Pharma

11.48 AM May 31st


Platinum Member


Dishman Pharma  

Dishman Pharma is likely to move to UC after 28.05.2014. This drug company will find support at Rs.125/- on account of excellent results. Your best time to pick up this stock at the bottom fishing zone.

8.43 PM May 26th


New Member



Drug Policy Control Order (DPCO) put a cap on the prices of 348 essential drugs, is likely to impact domestic revenue generation of both homegrown and multinational drug companies in 2014

12.55 PM May 15th


Platinum Member



, according to data tracker Dealogic. Many drug companies have paid down debt taken on during a buying spree in the earlier 2000s and are now generating lots of cash they want to put to work. Prescription drug makers are also attracted to acquisitions because deals can allow them cut costs and scale back

4.02 PM Apr 22nd


New Member


Aurobindo Pharm buy , rather accumulate Auro even at current levels for a 1-2 year timeframe. these US legalities are nothing new to Indian drug companies,happens all the time !

10.06 AM Apr 17th

Web Messenger

Platinum Member


Sun Pharma  

Source:VC Circle - Sun Pharmaceutical Industries Ltd, the country's top drugmaker by market cap, is acquiring Ranbaxy Laboratories Ltd in an all-stock transaction, creating the world's fifth-largest generics drug company and the largest pharma company in India by far

12.10 PM Apr 8th


Platinum Member


Sun Pharma  

Is it patent dispute with Drug company UCB?

9.16 PM Mar 18th


Gold Member


Vivimed Labs  

I am doctor by profession and knows the value of research and upcoming drugs. COMPANY has spent lot of rs in research and next quarter filing new ADNA / molecules which will drive the earning. you see almost 90% of shares are by institutes or large investor.

12.47 PM Mar 18th

Web Messenger

Platinum Member



Source:Calcutta Telegraph News - Mumbai, Feb. 20: Cipla has entered into an agreement with MSD to market the latter’s anti-HIV drug raltegravir in the country. This is the first time that Cipla is entering into a strategic partnership with a multinational drug company. MSD is the trade name

2.10 PM Feb 21st

News across the web »
Oct 29, 2014 at 20:01 | Source: Wall Street Journal
Oct 23, 2014 at 02:45 | Source: FirstPost
Explore Moneycontrol

Copyright © Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of is prohibited.